Method of administering antidepressant dosage form

• US 6,440,457 B1
• Filed: 05/27/1993
• Issued: 08/27/2002
• Est. Priority Date: 05/27/1993
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Bhatti, Gurdish Kaur, Edgren, David Emil, Hatamkhani, Zahedeh, Wong, Patrick S. L.
• Primary Examiner(s): Webman, Edward J.
• Application Number:
  US08/068,480
• Time in Patent Office: 3,379 Days
• Field of Search: 424/473, 424/468, 424/457, 514/964, 514/654
• US Class Current: 424/468
• CPC Class Codes: A61K 31/135 having aromatic rings , e.g. ketamine, nortriptyline methadone A61K31/137
• CPC Class Codes: A61K 9/0004 Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
• CPC Class Codes: A61P 25/24 Antidepressants
• CPC Class Codes: A61P 25/26 Psychostimulants, e.g. nicotine, cocaine

Abstract

The invention pertains to a dosage form 10 and to administering an antidepressant medicament 16 for an extended period of time in a rate-known dose.

Claims

1. A method for administering a drug to the gastrointestinal tract of a human, wherein the method comprises:

(a) admitting orally into the human a dosage form comprising a drug of the formula;

 

which drug possess antidepressant therapy and the dosage form comprises a member selected from the group consisting of a sustained-release dosage form and a controlled-release dosage form; and

,

(b) administering the drug from the dosage form over an extended period of time in a therapeutically responsive dose to produce the antidepressant therapy.